November, 2023

article thumbnail

Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

Pharmacy Times

Tune in to this episode of the Independent Rx Forum for a comprehensive overview of the National Community Pharmacists Association's legislative priorities, updates on critical pharmacy-related bills, and insights into the legislative process.

article thumbnail

Case study: The pinnacle of person-centred care in hospital pharmacy

Hospital Pharmacy Europe

In November 2022, London North West University Healthcare NHS Trust embarked on a person-centred care pilot that has changed the face of their pharmacy practice for the better. Helena Beer speaks to four of the key players about how they went about the ground-breaking project, the impact it’s having on patients, staff and the wider healthcare community, and their top tips for success.

Hospitals 131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

There Are Increasing Opportunities for Community Pharmacies to Help Patients With Anemia in Condition Management

Pharmacy Times

Pharmacies have the potential to introduce testing services, promote public health campaigns, collaborate with anemia-led clinics, and get more prescribing rights to diagnose anemia.

article thumbnail

Around 14% of Americans Have Experienced Long COVID Symptoms

Drug Topics

Although long COVID has emerged as a major public health concern, it has not yet been clearly identified as a clinical condition.

265
265
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Critics say HCA’s cost-cutting is endangering Appalachian patients — a warning for the whole U.S. health care system

STAT

ASHEVILLE, N.C. — There was the beeping of monitors, the stiff sheets, the sterile smell of the hospital room. Mostly, there was pain. Sharp, relentless pain. Mike Messino was recovering from a successful surgery, but the nerve blocks had worn off. He spent two full hours waiting for a nurse to inject pain medication. When he’d worked in this hospital, he’d made sure patients didn’t wait longer than 15 minutes for that kind of care.

Hospitals 145
article thumbnail

Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign

Fierce Pharma

With layoffs hitting employees on both sides of the Atlantic, Pfizer’s $3.5 billion cost-cutting spree has kicked it into high gear this month. | The company's Groton, Connecticut, research site is the latest to fall victim to job cuts as part of Pfizer's massive $3.5 billion cost-cutting mission, following layoffs across the U.S. and the U.K.

145
145

More Trending

article thumbnail

Despite decades of promises, health research still overlooks women

The Guardian - Pharmaceutical Industry

With White House initiative, Jill Biden aims to change that Women are twice as likely as men to die from heart attacks. When a nonsmoker dies of lung cancer, it’s twice as likely to be a woman as a man. Continue reading.

138
138
article thumbnail

Unveiling Progress and Challenges: C diff Awareness Among Medical Professionals

Pharmacy Times

Christian John Lillis, co-founder and executive director at Peggy Lillis Foundation, discusses the role of the pharmacist in education that advances C diff awareness in the medical community.

158
158
article thumbnail

Do you need antibiotics for strep throat?

The Checkup by Singlecare

Strep throat is one of the most common reasons for a sore throat. About 5% to 15% of sore throats in adults and 20% to 30% of sore throats in kids are caused by a strep infection, which is caused by group A streptococcus bacteria. If you or your child has strep throat, you may rush to the doctor to request an antibiotic—but do you actually need antibiotics to treat strep?

Hospitals 124
article thumbnail

STAT+: Mayo Clinic to spend $5 billion on tech-heavy redesign of its Minnesota campus

STAT

Mayo Clinic will spend $5 billion to reinvent its flagship medical campus in Rochester, Minn., infusing digital technologies into several new buildings designed to present a 21st-century vision of clinical care, the organization said Tuesday. The project, to include five new buildings with 2.4 million square feet of space, will merge Mayo’s traditional medical services with its increasing investments in artificial intelligence and digital tools.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA investigates 'serious risk' of secondary cancer following CAR-T treatment

Fierce Pharma

In a blow to CAR-T therapies, the FDA is investigating a “serious risk” of patients developing new cancers after treatment with these highly efficacious oncology drugs. | In a blow to CAR-T therapies, the FDA is investigating a “serious risk” of patients developing new cancers after treatment with these highly efficacious oncology drugs.

FDA 145
article thumbnail

CVS Health beats the Street with $2.3B in Q3 profit

Fierce Healthcare

CVS Health beat the Street on both earnings and revenue in the third quarter, reporting $2.3 billion in profit. | By comparison, the company reported a $3.4 billion loss in the third quarter of 2022 as it paid out its part in a global settlement over the opioid crisis.

145
145
article thumbnail

‘They thought I had cancer’: painkiller banned in UK linked to Britons’ deaths in Spain

The Guardian - Pharmaceutical Industry

Patients’ group says reactions to metamizole can cause sepsis and organ failure – and British and Irish people are at higher risk A patients group representing several British victims has launched legal action against the Spanish government over claims it failed to safeguard people against the potentially fatal side effects of one of the country’s most popular painkillers, involved in a series of serious illnesses and deaths.

132
132
article thumbnail

Vitamin D Supplementation During Pregnancy Reduced Rates of Asthma, Wheezing in Children

Pharmacy Times

Compared to the standard prenatal vitamin alone, vitamin D supplementation with the prenatal vitamin reduced the risk of asthma and wheezing in children by approximately 50%.

122
122
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Texas AG sues Pfiz­er and Tris Phar­ma for adul­ter­at­ed ADHD drug

Pharmaceutical Technology

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

141
141
article thumbnail

STAT+: Colon cancer prevention paradox: Higher-risk patients pay more for colonoscopy

STAT

Ashley Conway-Anderson was prepared for a lot of things when it came to her first colonoscopy. She sought out tips to make the daylong prep more bearable. She braced herself mentally for what the doctors would find; her mother, after all, was just a couple years out of recovery from colorectal cancer. When she awoke from the procedure, she said, things seemed relatively fine.

Insurance 144
article thumbnail

Moderna loses a COVID vaccine patent in Europe amid heated clash with BioNTech, Pfizer

Fierce Pharma

With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.

Vaccines 145
article thumbnail

Physician groups decry finalized Medicare payment cuts for 2024 as expenses rise

Fierce Healthcare

The Biden administration Thursday finalized policy changes for Medicare reimbursements in 2024 that will cut payments to physicians by 1.25% compared to 2023. | The Biden administration Thursday finalized policy changes for Medicare reimbursements in 2024 that will cut payments to physicians by 1.25% compared to 2023.

143
143
article thumbnail

Shock of the old: 10 scandalous vintage medicines – from asthma cigarettes to cocaine wine

The Guardian - Pharmaceutical Industry

Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.

Packaging 129
article thumbnail

Gene Therapy Advances in Hemophilia A Treatment

Pharmacy Times

Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the emergence of gene therapy as an exciting option for patients with hemophilia A and highlight benefits, limitations, and ongoing research in the field.

158
158
article thumbnail

Health Canada approves Jazz’s cannabis derived seizure therapy

Pharmaceutical Technology

Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two and older.

131
131
article thumbnail

STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma

STAT

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer. “Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory

FDA 145
article thumbnail

Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity

Fierce Pharma

In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival. | In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival.

144
144
article thumbnail

UnitedHealthcare hit with class action over alleged use of AI to deny Medicare Advantage claims

Fierce Healthcare

UnitedHealthcare is facing a potential class action lawsuit following allegations that it used an algorithm to deny claims for post-acute care services in Medicare Advantage. | UnitedHealthcare is facing a potential class action lawsuit following allegations that it used an algorithm to deny claims for post-acute care services in Medicare Advantage.

142
142
article thumbnail

Alliance for mRNA Medicines Officially Launched in Germany

BioPharm

The Alliance for mRNA Medicines (AMM) was officially launched at the 11th International mRNA Health Conference in Berlin, Germany.

133
133
article thumbnail

FDA Approves Defencath for Catheter-Related Infections for Those With Kidney Failure

Pharmacy Times

Taurolidine and heparin (Defencath; CorMedix) is indicated to reduce catheter-related bloodstream infections for adults with kidney failure who are receiving chronic hemodialysis via central venous catheter

FDA 156
article thumbnail

Japan grants approval for CSL and Arcturus’ Covid-19 vaccine 

Pharmaceutical Technology

Japan’s MHLW has approved CSL and Arcturus Therapeutics’ self-amplifying mRNA (sa-mRNA) Covid-19 vaccine, ARCT-154.

Vaccines 124
article thumbnail

Tanden, Becerra, Califf make time for a meeting with tobacco lobbyists on the menthol ban

STAT

WASHINGTON — A little-known group of Black law enforcement officers is getting significant access to the White House to talk about the FDA’s proposal to ban menthol cigarettes — and it’s bringing the tobacco industry along. Twenty-four Biden officials, including Food and Drug Administration Commissioner Robert Califf, HHS Secretary Xavier Becerra, and White House Domestic Policy Advisor Neera Tanden joined a call earlier this month with the National Organization of Bl

FDA 144
article thumbnail

Pfizer's cost-cutting campaign hits Sandwich site in UK, where 500 workers will lose jobs

Fierce Pharma

Earlier this month, Pfizer’s $3.5 billion cost-cutting campaign crossed overseas to Ireland. Now, just a week later, Pfizer is announcing hundreds more job cuts in the U.K. | Pfizer plans to cut approximately 500 roles and ax its Pharmaceutical Sciences Small Molecule capabilities at its site in Sandwich in Kent in the U.K. The move is a consequence of Pfizer’s enterprisewide cost realignment program, which the drugmaker unveiled in mid-October.

142
142
article thumbnail

Prior authorization and other regulatory burdens have increased since last year, practices tell MGMA

Fierce Healthcare

Nine in 10 polled medical practices say their regulatory burden has increased over the past year with prior authorization, audits and appeals, the Medicare Quality Payment Program (QPP) and require | The latest annual poll of practices' regulatory burden outlined prior authorization, audits and appeals, Medicare QPP and other leading pain points that physicians say are weighing down theor staff and ability to deliver care.

142
142
article thumbnail

Digitalization: The Route to Biopharma 4.0

BioPharm

The implementation of Industry 4.0 is projected to save time and cost for designing an optimal manufacturing process.

126
126
article thumbnail

FDA Approves Tirzepatide for Chronic Weight Management

Pharmacy Times

Tirzepatide is already approved under the brand name Mounjaro (Lilly) to be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.

FDA 156
article thumbnail

Talking techbio with NVIDIA: Accelerated computing, NLP, and GenAI in drug discovery

pharmaphorum

Talking techbio with NVIDIA: Accelerated computing, NLP, and GenAI in drug discovery Mike.

138
138
article thumbnail

Opinion: The next Census could undercount the number of disabled Americans by 20 million

STAT

About 20 million disabled people will be erased if the U.S. Census Bureau moves forward with changes to disability data collection methods. That is because many disabled people will no longer be counted as disabled by the new questions the Census is proposing to use starting in 2025 with the annual American Community Survey (ACS). As disabled people, and as scholars who study disability measurement and use disability data for our research, we have grave concerns about this proposed change.

145
145